Fewer Prevnar jabs just as effective

A new study demonstrates that three doses of Wyeth's pneumococcal vaccine Prevnar works as well as the four-dose regimen currently in use. And a reduction in jabs could save payers a significant amount of money. "In my opinion you could safely go to two-plus-one," Elisabeth Sanders, one of the study's co-authors, told Dow Jones. "Why not save the one injection if it's not required?" Report

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.